Understanding Dengue Virus Capsid Protein Interaction with Key Biological Targets

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Faustino, André F ^a   Martins, Ivo C ^a   Carvalho, Filomena A ^a   Castanho, Miguel A R B ^a   Maurer Stroh, Sebastian ^b,c   Santos, Nuno C ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b BIOINFORMATICS INSTITUTE   (Singapore)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CAPSID PROTEIN; MANNOSE 6 PHOSPHATE RECEPTOR BINDING PROTEIN 1; PEPTIDE; PLIN3 PROTEIN, HUMAN; PROTEIN BINDING; VERY LOW DENSITY LIPOPROTEIN; VESICULAR TRANSPORT PROTEIN;

AMINO ACID SEQUENCE; ATOMIC FORCE MICROSCOPY; CHEMISTRY; DENGUE VIRUS; HUMAN; METABOLISM; MOLECULAR DYNAMICS; MOLECULAR GENETICS; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; SEQUENCE ALIGNMENT;

AMINO ACID SEQUENCE; APOLIPOPROTEINS E; CAPSID PROTEINS; DENGUE VIRUS; HUMANS; LIPOPROTEINS, VLDL; MICROSCOPY, ATOMIC FORCE; MOLECULAR DYNAMICS SIMULATION; MOLECULAR SEQUENCE DATA; PEPTIDES; PERILIPIN-3; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; VESICULAR TRANSPORT PROTEINS;

EID: 84953896788     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10592     Document Type: Article

References (68)

1. Guzman, M. G. et al. Dengue: a continuing global threat. Nat. Rev. Microbiol. 8, S7-16 (2010).
2. Enserink, M. Entomology. A mosquito goes global. Science 320, 864-866 (2008).
3. Gubler, D. J. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol. 10, 100-103 (2002).
4. Gubler, D. J. The global pandemic of dengue/dengue haemorrhagic fever: current status and prospects for the future. Ann. Acad. Med. Singapore 27, 227-234 (1998).
5. Bhatt, S. et al. The global distribution and burden of dengue. Nature 496, 504-507 (2013).
6. Guzman, A. & Isturiz, R. E. Update on the global spread of dengue. Int. J. Antimicrob. Agents 36 (Suppl 1), S40-42 (2010).
7. Seneviratne, S. L., Malavige, G. N. & de Silva, H. J. Pathogenesis of liver involvement during dengue viral infections. Trans. R. Soc. Trop. Med. Hyg. 100, 608-614 (2006).
8. Suvarna, J. C. & Rane, P. P. Serum lipid profile: a predictor of clinical outcome in dengue infection. Trop. Med. Int. Health 14, 576-585 (2009).
9. Guzman, M. G., Alvarez, M. & Halstead, S. B. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch. Virol. 158, 1445-1459 (2013).
10. Lambrechts, L., Scott, T. W. & Gubler, D. J. Consequences of the expanding global distribution of Aedes albopictus for dengue virus transmission. PLOS Negl. Trop. Dis. 4, e646 (2010).
11. Reiter, P. Yellow fever and dengue: a threat to Europe? Euro Surveill. 15, 19509 (2010).
12. Knowlton, K., Solomon, G. & Rotkin-Ellman, M., Mosquito-Borne Dengue Fever Threat Spreading in the Americas. Natural Resources Defense Council Publications Department (July 2009). Available at: http://www.nrdc.org/health/dengue/files/dengue.pdf (Accessed: 6th March 2015).
13. La Ruche, G. et al. First two autochthonous dengue virus infections in metropolitan France, September 2010. Euro Surveill. 15, 19676 (2010).
14. Gjenero-Margan, I. et al. Autochthonous dengue fever in Croatia, August-September 2010. Euro Surveill. 16, 19805 (2011).
15. Alves, M. J. et al. Clinical presentation and laboratory findings for the first autochthonous cases of dengue fever in Madeira island, Portugal, October 2012. Euro Surveill. 18, 20398 (2013).
16. Sousa, C. A. et al. Ongoing outbreak of dengue type 1 in the Autonomous Region of Madeira, Portugal: preliminary report. Euro Surveill. 17, 20333 (2012).
17. Tomasello, D. & Schlagenhauf, P. Chikungunya and dengue autochthonous cases in Europe, 2007-2012. Travel Med. Infect. Dis. 11, 274-284 (2013).
18. Colwell, R. et al. Global climate change and infectious diseases. Emerg. Infect. Dis. 4, 451-452 (1998).
19. Enserink, M. Infectious Diseases. Yellow fever mosquito shows up in Northern Europe. Science 329, 736 (2010).
20. Capeding, M. R. et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet 384, 1358-1365 (2014).
21. Mukhopadhyay, S., Kuhn, R. J. & Rossmann, M. G. A structural perspective of the flavivirus life cycle. Nat. Rev. Microbiol. 3, 13-22 (2005).
22. Schweitzer, B. K., Chapman, N. M. & Iwen, P. C. Overview of the Flaviviridae With an Emphasis on the Japanese Encephalitis Group Viruses. Labmedicine 40, 493-499 (2009).
23. Martins, I. C. et al. The disordered N-terminal region of dengue virus capsid protein contains a lipid-droplet-binding motif. Biochem. J. 444, 405-415 (2012).
24. Noda, M. et al. Limited cross-reactivity of mouse monoclonal antibodies against Dengue virus capsid protein among four serotypes. Biologics 6, 409-416 (2012).
25. Kuhn, R. J. et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108, 717-725 (2002).
26. Jones, C. T. et al. Flavivirus capsid is a dimeric alpha-helical protein. J. Virol. 77, 7143-7149 (2003).
27. Ma, L., Jones, C. T., Groesch, T. D., Kuhn, R. J. & Post, C. B. Solution structure of dengue virus capsid protein reveals another fold. Proc. Natl. Acad. Sci. USA. 101, 3414-3419 (2004).
28. Martins IC, Almeida FCL, Santos NC, Da Poian AT; Universidade Federal do Rio de Janeiro (UFRJ), Universidade de Lisboa (UL), Instituto de Medicina Molecular (IMM). DENV-Derived Peptides and Methods for the Inhibition of the Flavivirus Replication. World Intellectual Property Organization (WIPO) patent International Publication Number WO 2012/159187. International Publication Date 2012 Nov 29.
29. Samsa, M. M. et al. Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLOS Pathog. 5, e1000632 (2009).
30. Carvalho, F. A. et al. Dengue Virus Capsid Protein Binding to Hepatic Lipid Droplets (LD) Is Potassium Ion Dependent and Is Mediated by LD Surface Proteins. J. Virol. 86, 2096-2108 (2012).
31. Faustino, A. F. et al. Dengue virus capsid protein interacts specifically with very low-density lipoproteins. Nanomedicine: NBM 10, 247-255 (2014).
32. Kimmel, A. R., Brasaemle, D. L., McAndrews-Hill, M., Sztalryd, C. & Londos, C. Adoption of PERILIPIN as a unifying nomenclature for the mammalian PAT-family of intracellular lipid storage droplet proteins. J. Lipid Res. 51, 468-471 (2010).
33. Faustino, A. F. et al. Understanding Dengue Virus Capsid Protein Disordered N-Terminus and pep14-23-Based Inhibition. ACS Chem. Biol. 10, 517-526 (2015).
34. André, P. et al. Characterization of low-and very-low-density hepatitis C virus RNA-containing particles. J. Virol. 76, 6919-6928 (2002).
35. Bartenschlager, R., Penin, F., Lohmann, V. & Andre, P. Assembly of infectious hepatitis C virus particles. Trends Microbiol. 19, 95-103 (2011).
36. Cushley, R. J. & Okon, M. NMR studies of lipoprotein structure. Annu. Rev. Biophys. Biomol. Struct. 31, 177-206 (2002).
37. Nelson, D. L. & Cox, M. M. in Lehninger Principles of Biochemistry 5th edn (eds Nelson, D. L. & Cox, M. M.) Ch. 21.4, 836-837 (W. H. Freeman and Company, 2008).
38. Chen, J., Li, Q. & Wang, J. Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions. Proc. Natl. Acad. Sci. USA. 108, 14813-14818 (2011).
39. Hickenbottom, S. J., Kimmel, A. R., Londos, C. & Hurley, J. H. Structure of a lipid droplet protein; the PAT family member TIP47. Structure 12, 1199-1207 (2004).
40. Weisgraber, K. H. Apolipoprotein E: structure-function relationships. Adv. Protein Chem. 45, 249-302 (1994).
41. Guttman, M., Prieto, J. H., Handel, T. M., Domaille, P. J. & Komives, E. A. Structure of the minimal interface between ApoE and LRP. J. Mol. Biol. 398, 306-319 (2010).
42. Fisher, C., Beglova, N. & Blacklow, S. C. Structure of an LDLR-RAP complex reveals a general mode for ligand recognition by lipoprotein receptors. Mol. Cell 22, 277-283 (2006).
43. Lund-Katz, S. et al. Effects of polymorphism on the microenvironment of the LDL receptor-binding region of human apoE. J. Lipid Res. 42, 894-901 (2001).
44. Nicodeme, P. Fast approximate motif statistics. J. Comput. Biol. 8, 235-248 (2001).
45. Gattiker, A., Gasteiger, E. & Bairoch, A. ScanProsite: a reference implementation of a PROSITE scanning tool. Appl. Bioinformatics 1, 107-108 (2002).
46. Thiam, A. R., Farese, R. V., Jr. & Walther, T. C. The biophysics and cell biology of lipid droplets. Nat. Rev. Mol. Cell Biol. 14, 775-786 (2013).
47. Farese, R. V., Jr. & Walther, T. C. Lipid droplets finally get a little R-E-S-P-E-C-T. Cell 139, 855-860 (2009).
48. Markoff, L., Falgout, B. & Chang, A. A conserved internal hydrophobic domain mediates the stable membrane integration of the dengue virus capsid protein. Virology 233, 105-117 (1997).
49. Nemésio, H., Palomares-Jerez, M. F. & Villalain, J. Hydrophobic segment of dengue virus C protein. Interaction with model membranes. Mol. Membr. Biol. 30, 273-287 (2013).
50. Carvalho, F. A. & Santos, N. C. Atomic force microscopy-based force spectroscopy-biological and biomedical applications. IUBMB Life 64, 465-472 (2012).
51. Diffenderfer, M. R. & Schaefer, E. J. The composition and metabolism of large and small LDL. Curr. Opin. Lipidol. 25, 221-226 (2014).
52. Sun, H. Y. et al. Comparative proteomic profiling of plasma very-low-density and low-density lipoproteins. Clin. Chim. Acta 411, 336-344 (2010).
53. Karlsson, H., Leanderson, P., Tagesson, C. & Lindahl, M. Lipoproteomics I: mapping of proteins in low-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry. Proteomics 5, 551-565 (2005).
54. Mendivil, C. O., Rimm, E. B., Furtado, J. & Sacks, F. M. Apolipoprotein E in VLDL and LDL with apolipoprotein C-III is associated with a lower risk of coronary heart disease. J. Am. Heart Assoc. 2, e000130 (2013).
55. Zheng, C., Khoo, C., Ikewaki, K. & Sacks, F. M. Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions. J. Lipid Res. 48, 1190-1203 (2007).
56. Cohn, J. S. et al. Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia. J. Lipid Res. 43, 1464-1471 (2002).
57. Campos, H., Perlov, D., Khoo, C. & Sacks, F. M. Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia. J. Lipid Res. 42, 1239-1249 (2001).
58. Liu, S. et al. Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding. Hepatology 56, 484-491 (2012).
59. Marazzi, I. et al. Suppression of the antiviral response by an influenza histone mimic. Nature 483, 428-433 (2012).
60. Petersen, T. N., Brunak, S., von Heijne, G. & Nielsen, H. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat. Methods 8, 785-786 (2011).
61. Thompson, J. D., Higgins, D. G. & Gibson, T. J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl. Acids Res. 22, 4673-4680 (1994).
62. Larkin, M. A. et al. Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947-2948 (2007).
63. IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature and symbolism for amino acids and peptides. Recommendations 1983. Eur. J. Biochem. 138, 9-37 (1984).
64. Hatters, D. M., Peters-Libeu, C. A. & Weisgraber, K. H. Engineering conformational destabilization into mouse apolipoprotein E. A model for a unique property of human apolipoprotein E4. J. Biol. Chem. 280, 26477-26482 (2005).
65. Pettersen, E. F. et al. UCSF Chimera - a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612 (2004).
66. Meng, E. C., Pettersen, E. F., Couch, G. S., Huang, C. C. & Ferrin, T. E. Tools for integrated sequence-structure analysis with UCSF Chimera. BMC Bioinformatics 7, 339 (2006).
67. Guex, N. & Peitsch, M. C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18, 2714-2723 (1997).
68. Carvalho, F. A. et al. Atomic force microscopy-based molecular recognition of a fibrinogen receptor on human erythrocytes. ACS Nano 4, 4609-4620 (2010).